Рак печени Результаты клинических исследований
-
A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizum
-
Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver
-
A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma
-
BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer
-
Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinom
-
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wi
-
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
-
Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer
-
A Study of Pexa-Vec (JX-594) Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma
-
A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib
-
A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma
-
Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
-
Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080
-
Safety and Bioactivity of Ipilimumab and Nivolumab Combination Prior to Liver Resection in Hepatocellular Carc
-
mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for
Исследования по заболеваниям
Рак лёгкогоНемелкоклеточный рак лёгкогоРак молочной железыКолоректальный ракРак желудкаРак печениРак поджелудочной железыРак простатыРак яичниковМеланомаЛейкозЛимфомаМножественная миеломаГлиобластомаДиабет 2 типаОжирениеГипертонияСердечная недостаточностьФибрилляция предсердийИнсультХроническая болезнь почекНАСГБолезнь АльцгеймераБолезнь ПаркинсонаРассеянный склерозДепрессияЭпилепсияБАСРевматоидный артритПсориазАтопический дерматитБолезнь КронаЯзвенный колитВолчанкаАстмаХОБЛ